Olli Silvennoinen

机构：University of Helsinki, Tampere University of Applied Sciences, Tampere University, Helsinki Institute of Physics, Czech Academy of Sciences, Institute of Biotechnology, Tampere University, Fimlab (Finland) · ORCID：0000-0003-0747-9512

发表论文 193 篇 · 总被引 21097 次 · h-index 73

代表论文

• Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases (2019 · BioDrugs · 被引 280)
• The regulation of JAKs in cytokine signaling and its breakdown in disease (2018 · Cytokine · 被引 222)
• Janus kinases to jakinibs: from basic insights to clinical practice (2019 · Lara D. Veeken · 被引 158)
• AI is a viable alternative to high throughput screening: a 318-target study (2024 · Scientific Reports · 被引 140)
• An Activating STAT3 Mutation Causes Neonatal Diabetes through Premature Induction of Pancreatic Differentiation (2017 · Cell Reports · 被引 108)
• JAK inhibitor selectivity: new opportunities, better drugs? (2024 · Nature Reviews Rheumatology · 被引 105)